These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 22486623)

  • 1. Enhanced delivery of chemotherapy to tumors using a multicomponent nanochain with radio-frequency-tunable drug release.
    Peiris PM; Bauer L; Toy R; Tran E; Pansky J; Doolittle E; Schmidt E; Hayden E; Mayer A; Keri RA; Griswold MA; Karathanasis E
    ACS Nano; 2012 May; 6(5):4157-68. PubMed ID: 22486623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On-command drug release from nanochains inhibits growth of breast tumors.
    Peiris PM; Tam M; Vicente P; Abramowski A; Toy R; Bauer L; Mayer A; Pansky J; Doolittle E; Tucci S; Schmidt E; Shoup C; Rao S; Murray K; Gopalakrishnan R; Keri RA; Basilion JP; Griswold MA; Karathanasis E
    Pharm Res; 2014 Jun; 31(6):1460-8. PubMed ID: 23934254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Invasive Brain Tumors Using a Chain-like Nanoparticle.
    Peiris PM; Abramowski A; Mcginnity J; Doolittle E; Toy R; Gopalakrishnan R; Shah S; Bauer L; Ghaghada KB; Hoimes C; Brady-Kalnay SM; Basilion JP; Griswold MA; Karathanasis E
    Cancer Res; 2015 Apr; 75(7):1356-65. PubMed ID: 25627979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crossing the barrier: treatment of brain tumors using nanochain particles.
    Karathanasis E; Ghaghada KB
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):678-95. PubMed ID: 26749497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined radiofrequency ablation and adjuvant liposomal chemotherapy: effect of chemotherapeutic agent, nanoparticle size, and circulation time.
    Ahmed M; Lukyanov AN; Torchilin V; Tournier H; Schneider AN; Goldberg SN
    J Vasc Interv Radiol; 2005 Oct; 16(10):1365-71. PubMed ID: 16221908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnologies for noninvasive measurement of drug release.
    Moore T; Chen H; Morrison R; Wang F; Anker JN; Alexis F
    Mol Pharm; 2014 Jan; 11(1):24-39. PubMed ID: 24215280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of cancer micrometastasis using a multicomponent chain-like nanoparticle.
    Peiris PM; Toy R; Abramowski A; Vicente P; Tucci S; Bauer L; Mayer A; Tam M; Doolittle E; Pansky J; Tran E; Lin D; Schiemann WP; Ghaghada KB; Griswold MA; Karathanasis E
    J Control Release; 2014 Jan; 173():51-8. PubMed ID: 24188960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticles for delivery of chemotherapeutic agents to tumors.
    Vijayaraghavalu S; Raghavan D; Labhasetwar V
    Curr Opin Investig Drugs; 2007 Jun; 8(6):477-84. PubMed ID: 17621878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circumventing tumor resistance to chemotherapy by nanotechnology.
    Liang XJ; Chen C; Zhao Y; Wang PC
    Methods Mol Biol; 2010; 596():467-88. PubMed ID: 19949937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor vascular-targeted co-delivery of anti-angiogenesis and chemotherapeutic agents by mesoporous silica nanoparticle-based drug delivery system for synergetic therapy of tumor.
    Li X; Wu M; Pan L; Shi J
    Int J Nanomedicine; 2016; 11():93-105. PubMed ID: 26766908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Core-matched nanoassemblies for targeted co-delivery of chemotherapy and photosensitizer to treat drug-resistant cancer.
    Jiang D; Xu M; Pei Y; Huang Y; Chen Y; Ma F; Lu H; Chen J
    Acta Biomater; 2019 Apr; 88():406-421. PubMed ID: 30763634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
    Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
    Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanohybrid liposomal cerasomes with good physiological stability and rapid temperature responsiveness for high intensity focused ultrasound triggered local chemotherapy of cancer.
    Liang X; Gao J; Jiang L; Luo J; Jing L; Li X; Jin Y; Dai Z
    ACS Nano; 2015 Feb; 9(2):1280-93. PubMed ID: 25599568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of nanoparticles in the improvement of systemic anticancer drug delivery.
    Field LD; Nag OK; Sangtani A; Burns KE; Delehanty JB
    Ther Deliv; 2018 Jul; 9(7):527-545. PubMed ID: 29943689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin.
    Ma X; Teh C; Zhang Q; Borah P; Choong C; Korzh V; Zhao Y
    Antioxid Redox Signal; 2014 Aug; 21(5):707-22. PubMed ID: 23931896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors.
    Manzoor AA; Lindner LH; Landon CD; Park JY; Simnick AJ; Dreher MR; Das S; Hanna G; Park W; Chilkoti A; Koning GA; ten Hagen TL; Needham D; Dewhirst MW
    Cancer Res; 2012 Nov; 72(21):5566-75. PubMed ID: 22952218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice.
    Zhang RX; Zhang T; Chen K; Cheng J; Lai P; Rauth AM; Pang KS; Wu XY
    J Vis Exp; 2017 Oct; (128):. PubMed ID: 29053672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles.
    Alavi M; Hamidi M
    Drug Metab Pers Ther; 2019 Feb; 34(1):. PubMed ID: 30707682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nano-Engineered Mesenchymal Stem Cells Increase Therapeutic Efficacy of Anticancer Drug Through True Active Tumor Targeting.
    Layek B; Sadhukha T; Panyam J; Prabha S
    Mol Cancer Ther; 2018 Jun; 17(6):1196-1206. PubMed ID: 29592881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.